Cantor Fitzgerald Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Buy	259,032 +2,779	+1%	+$160K	1.01%	33
2026 Q1	$15.5M	Sell	256,253 -2,880	-1%	-$168K	1.15%	25
2025 Q4	$14M	Sell	259,133 -30,582	-11%	-$1.47M	1.04%	30
2025 Q3	$13.1M	Buy	289,715 +18,267	+7%	+$853K	0.89%	41
2025 Q2	$12.6M	Buy	271,448 +548	+0.2%	+$26.9K	0.89%	44
2025 Q1	$16.5M	Sell	270,900 -24,820	-8%	-$1.45M	1.2%	25
2024 Q4	$16.7M	Buy	295,720 +183	+0.1%	+$10.2K	1.16%	29
2024 Q3	$15.3M	Buy	295,537 +529	+0.2%	+$24.8K	1.04%	44
2024 Q2	$12.3M	Buy	295,008 +63,737	+28%	+$2.85M	0.94%	48
2024 Q1	$12.5M	Sell	231,271 -2,903	-1%	-$148K	0.93%	46
2023 Q4	$12M	Buy	+234,174	New	+$12.3M	0.93%	43
2022 Q1	$22.4M	Buy	306,176 +146,248	+91%	+$9.82M	1%	41
2021 Q4	$9.97M	Buy	159,928 +2,509	+2%	+$147K	0.6%	48
2021 Q3	$9.31M	Buy	157,419 +430	+0.3%	+$28.3K	0.69%	47
2021 Q2	$10.5M	Buy	+156,989	New	+$10.2M	0.77%	41

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's BMY Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.1% in Q2 2026, buying an estimated $160K and bringing the position to 259,032 shares worth $14.9M. The position accounts for 1.01% of the portfolio, ranked #33.

Cantor Fitzgerald Investment Advisors first reported a position in BMY in Q2 2021 and has held it in 15 quarters since. The position peaked at $22.4M in Q1 2022. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cantor Fitzgerald Investment Advisors held 259,032 shares of Bristol-Myers Squibb worth $14.9M as of Q2 2026.
Cantor Fitzgerald Investment Advisors bought 2,779 Bristol-Myers Squibb shares in Q2 2026, an estimated $160K.
Bristol-Myers Squibb made up 1.01% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #33 holding.
Cantor Fitzgerald Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 15 quarters since.
Cantor Fitzgerald Investment Advisors's Bristol-Myers Squibb position peaked at $22.4M in Q1 2022.
1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.